- Editor: Victor Torres
- Author: 神奇四侠
- Translator: Ranting
Former National Counterintelligence and Security Center director Bill Evanina recently revealed in a CBS television interview that when a serious outbreak of the coronavirus occurred in Washington State last March, the world’s largest biotechnology company based in the Chinese Communist Party, the BGI Group, offered to help manage a sophisticated coronavirus testing laboratory, provide technical expertise, high-throughput sequencing technology, and even make a donation. BGI Group has also proposed to several states, including California and New York, to establish and operate coronavirus testing centers.
After the outbreak of the CCP virus, the personnel of BGI Group tried to distribute its products contacted at least 11 states in the United States to promote testing products to enter government-run laboratories or establish entire laboratories.
U.S. officials are very skeptical and concerned about the BGI Group proposal and its ties to the CCP government. Bill Evanina, the top counterintelligence official, then ordered a bulletin to state governments, hospitals, clinics, and interested groups warning that “outside powers may collect, store, and use biometric information obtained through CCP virus testing,” and that the genetic data would go to an unknown destination. BGI Group has denied any involvement in the conduct in the warning in question.
Reuters recently reported that more than 40 publicly available documents and research papers in English and Chinese show that the BGI Group has collaborative relationships with the Chinese military, and U.S. officials have said that the Chinese Communist Party has conducted genetic data collection in the United States. BGI Group acquired Complete Genomics, a US-based third-generation sequencing company, in 2013. Harbin Pharmaceutical Group also acquired the bankrupt health product maker GNC in September 2020. Currently, there are at least 23 CCP-linked companies engaged in the genetic testing business in the United States.
In June 2019, the Chinese Communist Party issued the “Regulations on Human Genetic Resources Management,” which stipulates that foreign organizations and domestic and foreign institutions established by foreign organizations and individuals, including organizations, enterprises or individuals in Hong Kong, Macao and Taiwan, and institutions established by them, shall not collect, trade, export, or exit human genetic information resources in China, while Chinese genetic companies , medical institutions, etc. shall not carry out international cooperative research on human genetic information in China or pass human genetic information out of China with foreign institutions without permission.
The CCP government used the global pandemic crisis to collect as much genetic data as possible. According to CCP media reports, the CCP has signed international clinical (phase III) agreements for inactivated vaccines with a number of countries, including the UAE, Bahrain, Peru, Morocco, and Argentina, in the midst of competition for vaccine development and testing that is taking place in major countries around the world. The CCP may be able to obtain genetic data from tens of thousands of participants in these countries.
The CCP conducted DNA collection from ethnic minorities in Tibet and Xinjiang in 2013 and 2016, respectively, in the name of annual health checks. Since the end of 2017, this program has been expanded to other regions in China. The CCP government has collected DNA samples from 35 to 70 million men since the end of 2017. The CCP already has the world’s largest repository of genetic material, with a total of 80 million genetic data.